SLC25A13 and gastric adenocarcinoma: The majority of the stomach adenocarcinoma samples were either diploid (48%) or exhibited a gain (38%) of the citrin gene; the remaining samples exhibited shallow deletions, amplifications, and a loss of the citrin gene (Figure 4M).